Cargando…

Resolution of Pain and Predictors of Postoperative Opioid use after Bridge-Enhanced Anterior Cruciate Ligament Repair and Anterior Cruciate Ligament Reconstruction

PURPOSE: To compare postoperative pain scores and opioid use between patients undergoing a standard arthroscopic anterior cruciate ligament reconstruction (ACLR) using hamstring autograft with those undergoing a suture repair augmented with an extracellular matrix scaffold (bridge-enhanced ACL repai...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnett, Samuel, Murray, Martha M., Liu, Shanshan, Micheli, Lyle J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283945/
https://www.ncbi.nlm.nih.gov/pubmed/32548587
http://dx.doi.org/10.1016/j.asmr.2020.02.004
_version_ 1783544364273762304
author Barnett, Samuel
Murray, Martha M.
Liu, Shanshan
Micheli, Lyle J.
author_facet Barnett, Samuel
Murray, Martha M.
Liu, Shanshan
Micheli, Lyle J.
author_sort Barnett, Samuel
collection PubMed
description PURPOSE: To compare postoperative pain scores and opioid use between patients undergoing a standard arthroscopic anterior cruciate ligament reconstruction (ACLR) using hamstring autograft with those undergoing a suture repair augmented with an extracellular matrix scaffold (bridge-enhanced ACL repair) performed through an arthrotomy and to determine factors predictive of postoperative opioid use and levels of overprescription. METHODS: A nonrandomized controlled trial was conducted with 20 patients (10 ACLR, 10 bridge-enhanced ACL repair), aged 18 to 35 years. All surgeries were performed by a single surgeon. A pain medication log was provided to patients on discharge. No regional anesthesia was performed. Pain scores via a visual analog pain scale were recorded at each visit. Correlations between preoperative and intraoperative characteristics and postoperative opioid use were determined. RESULTS: The total morphine-equivalent dose ranged from 30 to 309 mg (4-42 pills oxycodone) for the ACLR group and 75 to 254 mg (10-34 pills oxycodone) for the bridge-enhanced ACL repair group. The average opioid use per day was 35.8 mg for the patients undergoing bridge-enhanced ACL repair and 44.2 mg for patients undergoing ACLR (P = .29). Pain scores at time points up to 2 years postoperatively were not significantly different between the 2 groups. Across both groups, the average oversupply of oxycodone was 46 pills per patient, a greater than 70% unused opiate rate. Preoperative body mass index and preoperative Knee Injury and Osteoarthritis Outcome Scores pain score were predictive of greater postoperative opioid use per day, whereas age, concurrent meniscal repair, and operative time were not. CONCLUSIONS: Total overall opiate intake was not different between the patients undergoing bridge-enhanced ACL repair through an arthrotomy and those undergoing arthroscopic ACLR. Both groups had similar pain scores from 2 weeks to 2 years postoperatively. Greater body mass index and greater preoperative pain (lower Knee Injury and Osteoarthritis Outcome Scores pain score) correlated with greater postoperative opioid use per day. There was an overprescription of opioids across all patients. LEVEL OF EVIDENCE: Level III, case control study (therapeutic).
format Online
Article
Text
id pubmed-7283945
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72839452020-06-15 Resolution of Pain and Predictors of Postoperative Opioid use after Bridge-Enhanced Anterior Cruciate Ligament Repair and Anterior Cruciate Ligament Reconstruction Barnett, Samuel Murray, Martha M. Liu, Shanshan Micheli, Lyle J. Arthrosc Sports Med Rehabil Original Article PURPOSE: To compare postoperative pain scores and opioid use between patients undergoing a standard arthroscopic anterior cruciate ligament reconstruction (ACLR) using hamstring autograft with those undergoing a suture repair augmented with an extracellular matrix scaffold (bridge-enhanced ACL repair) performed through an arthrotomy and to determine factors predictive of postoperative opioid use and levels of overprescription. METHODS: A nonrandomized controlled trial was conducted with 20 patients (10 ACLR, 10 bridge-enhanced ACL repair), aged 18 to 35 years. All surgeries were performed by a single surgeon. A pain medication log was provided to patients on discharge. No regional anesthesia was performed. Pain scores via a visual analog pain scale were recorded at each visit. Correlations between preoperative and intraoperative characteristics and postoperative opioid use were determined. RESULTS: The total morphine-equivalent dose ranged from 30 to 309 mg (4-42 pills oxycodone) for the ACLR group and 75 to 254 mg (10-34 pills oxycodone) for the bridge-enhanced ACL repair group. The average opioid use per day was 35.8 mg for the patients undergoing bridge-enhanced ACL repair and 44.2 mg for patients undergoing ACLR (P = .29). Pain scores at time points up to 2 years postoperatively were not significantly different between the 2 groups. Across both groups, the average oversupply of oxycodone was 46 pills per patient, a greater than 70% unused opiate rate. Preoperative body mass index and preoperative Knee Injury and Osteoarthritis Outcome Scores pain score were predictive of greater postoperative opioid use per day, whereas age, concurrent meniscal repair, and operative time were not. CONCLUSIONS: Total overall opiate intake was not different between the patients undergoing bridge-enhanced ACL repair through an arthrotomy and those undergoing arthroscopic ACLR. Both groups had similar pain scores from 2 weeks to 2 years postoperatively. Greater body mass index and greater preoperative pain (lower Knee Injury and Osteoarthritis Outcome Scores pain score) correlated with greater postoperative opioid use per day. There was an overprescription of opioids across all patients. LEVEL OF EVIDENCE: Level III, case control study (therapeutic). Elsevier 2020-05-14 /pmc/articles/PMC7283945/ /pubmed/32548587 http://dx.doi.org/10.1016/j.asmr.2020.02.004 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Barnett, Samuel
Murray, Martha M.
Liu, Shanshan
Micheli, Lyle J.
Resolution of Pain and Predictors of Postoperative Opioid use after Bridge-Enhanced Anterior Cruciate Ligament Repair and Anterior Cruciate Ligament Reconstruction
title Resolution of Pain and Predictors of Postoperative Opioid use after Bridge-Enhanced Anterior Cruciate Ligament Repair and Anterior Cruciate Ligament Reconstruction
title_full Resolution of Pain and Predictors of Postoperative Opioid use after Bridge-Enhanced Anterior Cruciate Ligament Repair and Anterior Cruciate Ligament Reconstruction
title_fullStr Resolution of Pain and Predictors of Postoperative Opioid use after Bridge-Enhanced Anterior Cruciate Ligament Repair and Anterior Cruciate Ligament Reconstruction
title_full_unstemmed Resolution of Pain and Predictors of Postoperative Opioid use after Bridge-Enhanced Anterior Cruciate Ligament Repair and Anterior Cruciate Ligament Reconstruction
title_short Resolution of Pain and Predictors of Postoperative Opioid use after Bridge-Enhanced Anterior Cruciate Ligament Repair and Anterior Cruciate Ligament Reconstruction
title_sort resolution of pain and predictors of postoperative opioid use after bridge-enhanced anterior cruciate ligament repair and anterior cruciate ligament reconstruction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283945/
https://www.ncbi.nlm.nih.gov/pubmed/32548587
http://dx.doi.org/10.1016/j.asmr.2020.02.004
work_keys_str_mv AT barnettsamuel resolutionofpainandpredictorsofpostoperativeopioiduseafterbridgeenhancedanteriorcruciateligamentrepairandanteriorcruciateligamentreconstruction
AT murraymartham resolutionofpainandpredictorsofpostoperativeopioiduseafterbridgeenhancedanteriorcruciateligamentrepairandanteriorcruciateligamentreconstruction
AT liushanshan resolutionofpainandpredictorsofpostoperativeopioiduseafterbridgeenhancedanteriorcruciateligamentrepairandanteriorcruciateligamentreconstruction
AT resolutionofpainandpredictorsofpostoperativeopioiduseafterbridgeenhancedanteriorcruciateligamentrepairandanteriorcruciateligamentreconstruction
AT michelilylej resolutionofpainandpredictorsofpostoperativeopioiduseafterbridgeenhancedanteriorcruciateligamentrepairandanteriorcruciateligamentreconstruction